Serbia fails to sell 25% of drug maker Galenika
, NewsSerbia’s economy ministry said it has failed to reach an agreement with a consortium of UK-based Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm on the sale of 25% of majority state-owned drug maker Galenika.
The government plans to abandon the model for privatisation of Galenika through subscription of a capital hike by a strategic investor and find another model, the economy ministry said in a statement on Wednesday.
The ministry added that the government has already discussed the restructuring of Galenika’s outstanding debt with the company’s management.
The sale failed because the consortium had been unable to strike a deal on Galenika’s 70 million euro ($75 million) debt with five bank creditors, public broadcaster Radio Televizija Srbije (RTS) quoted trade union Nezavisnost representative Zoran Pantelic as saying on Wednesday. The consortium was ready to assume one-fifth of Galenika’s debt and cut in half the company’s 1,400-strong workforce, RTS said.
Galenika is currently stable and will have no problems in servicing its short-term debt. Therefore, the government has ordered the relevant authorities not to block the bank accounts of the company until March 31, 2017, the ministry said.
The British-Russian consortium has reportedly offered 7 million euro for the 25% shareholding interest. It was the only bidder left in the race after the bids submitted by India’s Cadila Pharmaceutical and Brazil’s EMS SA were rejected over procedural flaws.
The Serbian state controls 70% of Galenika directly and a further 15% via state-owned investment fund Akcionarski Fond Beograd. The remainder is controlled by retail shareholders.
LATEST NEWS
- May 11, 2023 Mining Industry, Science and Communications, bridging the gaps
- May 11, 2023 Communicating Energy, new tech industries communications
- May 9, 2023 Serbia economy briefing: Transformation of “Elektroprivreda Srbija”
- April 24, 2023 Without sustainable mining, there is no renewable future
- March 25, 2023 Europe revives mining to reduce dependence on the import of key raw materials, the advantages of Serbia as materials supplier
- March 8, 2023 Calcium Carbonate Industry, Reshaping the Market Growth, Serbian supplier to match European industrial demand
- February 28, 2023 Serbian exploitation miner Belkalhan could become EU primary supplier of Graphite critical raw material
- February 28, 2023 Calcite/calcium carbonate premium quality supplier from Serbia opening supply contracts for 24,25, pharmaceutical/chemical/food processing industry opportunity for JV
- February 16, 2023 Serbian Belkalhan calcite & graphite mining developer invites JV partners for joint critical raw materials exploitation
- February 15, 2023 Petroprocess to modernize EPS power plant CEMS system with state of the art equipment
- June 4, 2023 Serbia, Is gold laying under the dust?
- June 4, 2023 Air Serbia’s popularity and traffic are increasing
- June 4, 2023 Is gold fever taking over in Serbia?
